FP 1770
Alternative Names: FP1770Latest Information Update: 20 Nov 2009
Price :
$50 *
At a glance
- Originator Faust Pharmaceuticals
- Developer Domain Therapeutics
- Class Small molecules
- Mechanism of Action Metabotropic glutamate receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Anxiety disorders; Major depressive disorder; Parkinson's disease; Schizophrenia; Substance-related disorders
Most Recent Events
- 25 Jan 2007 No development reported - Preclinical for Depression in France (unspecified route)
- 25 Jul 2006 Preclinical trials in Schizophrenia in France (unspecified route)
- 25 Jul 2006 Preclinical trials in Substance-related disorders in France (unspecified route)